| | Class 2 Device Recall MyLab Gamma (Model 7410) |  |
| Date Initiated by Firm | June 11, 2018 |
| Create Date | October 23, 2018 |
| Recall Status1 |
Terminated 3 on May 12, 2020 |
| Recall Number | Z-0205-2019 |
| Recall Event ID |
81285 |
| 510(K)Number | K142008 K142077 K161359 |
| Product Classification |
System, imaging, pulsed doppler, ultrasonic - Product Code IYN
|
| Product | MyLab Gamma, Model 7410 |
| Code Information |
n/a |
| FEI Number |
3012981490
|
Recalling Firm/ Manufacturer |
ESAOTE S.P.A. Sesto Fiorentino Via Degli Olmi 11 Sesto Fiorentino Italy
|
Manufacturer Reason for Recall | The probe power monitoring settings have been found to be not appropriate under
specific operating conditions when connected to the devices listed below. This issue may result in overheating of the probe head. The probe power monitoring settings may not be effective in specific operating conditions so that the surface of the probe head may overheat in around one minute of continuous operations. The patient may experience discomfort, reddening of epidermis and/or mild pain. To date, no patient injury has been reported with regards to this issue. |
FDA Determined Cause 2 | Software design |
| Action | On June 11, 2018, the firm notified IH 6-18 probe customers of the product issue through a Field Safety Notice. The letter described the issue and stated that Esaote would provide and install a corrective software update for each affected unit at no cost to the customer.
Until the customer receives the corrective software update, customer is requested to refrain from
use of the probe IH 618 in BTEI mode or any combined mode including BTEI in Pediatric,
Neonatal and Intraoperative clinical applications.
For all the other applications, you are requested to monitor the possible temperature rise at the
surface of the probe head and immediately stop scanning if the patient notices any discomfort.
As a general safety rule, it is recommended to use the probe in default settings, to keep the
examination time as short as is necessary to produce a useful diagnostic result and not to hold the
probe in a fixed position for any longer than is strictly necessary.
Customers are requested to distribute this Field Safety Notice to all appropriate personnel in their
organization and forward to all users of the systems, including others to whom they may have
transferred the systems, in which case the customer is requested to provide information to Esaote regarding
the new owner. |
| Quantity in Commerce | 10 |
| Distribution | Worldwide distribution - US Nationwide in the states of AK, AZ, CA, IN, MO, NM, PA, SC, and TX. and countries Argentina and
Australia
Austria
Bangladesh
Belgium
Brazil
Bulgaria
China
Costa Rica
Denmark
Egypt
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India
Iran
Italy
Japan
Kuwait
Mexico
Netherlands
Norway
Paraguay
Poland
Portugal
Russian Fed.
Saudi Arabia
Singapore
Slovenia
South Africa
South Korea
Spain
Switzerland
Taiwan
Thailand
Tunisia
Turkey
United Kingdom
Utd.Arab Emir. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
| 510(K) Database | 510(K)s with Product Code = IYN
|
|
|
|